Global IV Fluids Market

IV Fluids Comprehensive Study by Type (Colloids, Crystalloids, Blood and blood products, Oxygen-carrying solutions), Composition (Normal Saline {0.9% Normal Saline (0.9% NaCl}, Hypertonic saline {3, 5, & 7.5%}, Lactated Ringer’s, Dextran, D5W {5% dextrose in water}, Whole blood, Platelets, Others), End User (Hospitals, Clinics, Ambulatory surgery centers, Others) Players and Region - Global Market Outlook to 2030

IV Fluids Market by XX Submarkets | Forecast Years 2024-2030  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
About IV Fluids
The Intravenous fluids are chemically prepared solutions that are administered to the patient at the time of serious dehydration. They’re tailored to the body’s needs and used to replace lost fluid and/or aid within the delivery of IV medications. For patients that don't require immediate fluid or drug, the continuous delivery of a small quantity of IV fluid can be used to keep a vein patent (open) for future use. IV fluids are available in different forms and have different impacts on the body. Therefore, it's important to have an understanding of the various types of IV fluids, along with their indications to be used.

AttributesDetails
Study Period2018-2030
Base Year2023
UnitValue (USD Million)


Competition among existing players is due to the IV Fluids market share occupied by leading players. The industry leader is engaged in offering innovative and superior quality products to cater to the ever-growing demand for IV Fluids Market. The companies are implementing strategic activities such as acquisitions and mergers along with collaboration with companies in other industries to aid them in improving sustenance and maintaining their competitive advantage. Analyst at AMA Research estimates that Germany Players will contribute the maximum growth to Global IV Fluids market throughout the forecasted period. Established and emerging Players should take a closer view at their existing organizations and reinvent traditional business and operating models to adapt to the future.

B. Braun Melsungen AG (Germany), Baxter (United Kingdom), Fresenius Kabi AG (Germany), Grifols (United States), ICU Medical, Inc. (United States), Omnicare (United States), JW Life Science (South Korea), Hospira Inc. (United States), Sichuan Kelun Pharmaceutical (China) and Vifor Pharma (Switzerland) are some of the key players that are part of study coverage. Additionally, the Players which are also part of the research coverage are Fresenius Kabi (Germany) and Claris Lifesciences (India).

Segmentation Overview
AMA Research has segmented the market of Global IV Fluids market by Type (Colloids, Crystalloids, Blood and blood products and Oxygen-carrying solutions) and Region.



On the basis of geography, the market of IV Fluids has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). If we see Market by Composition, the sub-segment i.e. Normal Saline {0.9% Normal Saline (0.9% NaCl} will boost the IV Fluids market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth. If we see Market by End User, the sub-segment i.e. Hospitals will boost the IV Fluids market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.

Market Growth Drivers:
Increasing Prevalence of Diarrhea, The Rising Geriatric Population and The Rising Diseases like Cancer & Diabetes across the Globe

Challenges:
The Presence of Domestic Players Which Provide Low-Quality Products

Restraints:
Stringent Government Regulations

Opportunities:
Continuous Emerging Demand from Economies

Market Leaders and their expansionary development strategies
In March 2022, Baxter International Inc., a globally diversified healthcare company, and ApaTech, a U.K.-based orthobiologic products company supported by private equity, entered into a definitive agreement. Under this agreement, Baxter acquired the entire outstanding equity of ApaTech for a total consideration of up to USD 330 million. The acquisition will grant Baxter ownership of ACTIFUSE, a synthetic bone graft material composed of silicate substituted calcium phosphate.
In March 2022, Digital Diagnostics and Baxter International Inc. partnered, aimed at supporting frontline care providers in delivering exceptional healthcare and enhancing patient outcomes. As part of this collaboration, they intend to provide Digital Diagnostics' renowned IDx-DR® autonomous AI software as a diagnostic service, in conjunction with the Welch Allyn® RetinaVue® 700 Imager.


Key Target Audience
IV Fluids Manufacturers, IV Fluids Distributors, IV Fluids Importer/Exporter, Regulatory & Government Bodies and Downstream Vendors

About Approach
To evaluate and validate the market size various sources including primary and secondary analysis is utilized. AMA Research follows regulatory standards such as NAICS/SIC/ICB/TRCB, to have a better understanding of the market. The market study is conducted on basis of more than 200 companies dealing in the market regional as well as global areas with the purpose to understand the companies positioning regarding the market value, volume, and their market share for regional as well as global.

Further to bring relevance specific to any niche market we set and apply a number of criteria like Geographic Footprints, Regional Segments of Revenue, Operational Centres, etc. The next step is to finalize a team (In-House + Data Agencies) who then starts collecting C & D level executives and profiles, Industry experts, Opinion leaders, etc., and work towards appointment generation.

The primary research is performed by taking the interviews of executives of various companies dealing in the market as well as using the survey reports, research institute, and latest research reports. Meanwhile, the analyst team keeps preparing a set of questionnaires, and after getting the appointee list; the target audience is then tapped and segregated with various mediums and channels that are feasible for making connections that including email communication, telephonic, skype, LinkedIn Group & InMail, Community Forums, Community Forums, open Survey, SurveyMonkey, etc.

Report Objectives / Segmentation Covered

By Type
  • Colloids
  • Crystalloids
  • Blood and blood products
  • Oxygen-carrying solutions
By Composition
  • Normal Saline {0.9% Normal Saline (0.9% NaCl}
  • Hypertonic saline {3, 5, & 7.5%}
  • Lactated Ringer’s
  • Dextran
  • D5W {5% dextrose in water}
  • Whole blood
  • Platelets
  • Others

By End User
  • Hospitals
  • Clinics
  • Ambulatory surgery centers
  • Others

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Increasing Prevalence of Diarrhea
      • 3.2.2. The Rising Geriatric Population
      • 3.2.3. The Rising Diseases like Cancer & Diabetes across the Globe
    • 3.3. Market Challenges
      • 3.3.1. The Presence of Domestic Players Which Provide Low-Quality Products
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global IV Fluids, by Type, Composition, End User and Region (value, volume and price ) (2018-2023)
    • 5.1. Introduction
    • 5.2. Global IV Fluids (Value)
      • 5.2.1. Global IV Fluids by: Type (Value)
        • 5.2.1.1. Colloids
        • 5.2.1.2. Crystalloids
        • 5.2.1.3. Blood and blood products
        • 5.2.1.4. Oxygen-carrying solutions
      • 5.2.2. Global IV Fluids by: Composition (Value)
        • 5.2.2.1. Normal Saline {0.9% Normal Saline (0.9% NaCl}
        • 5.2.2.2. Hypertonic saline {3, 5, & 7.5%}
        • 5.2.2.3. Lactated Ringer’s
        • 5.2.2.4. Dextran
        • 5.2.2.5. D5W {5% dextrose in water}
        • 5.2.2.6. Whole blood
        • 5.2.2.7. Platelets
        • 5.2.2.8. Others
      • 5.2.3. Global IV Fluids by: End User (Value)
        • 5.2.3.1. Hospitals
        • 5.2.3.2. Clinics
        • 5.2.3.3. Ambulatory surgery centers
        • 5.2.3.4. Others
      • 5.2.4. Global IV Fluids Region
        • 5.2.4.1. South America
          • 5.2.4.1.1. Brazil
          • 5.2.4.1.2. Argentina
          • 5.2.4.1.3. Rest of South America
        • 5.2.4.2. Asia Pacific
          • 5.2.4.2.1. China
          • 5.2.4.2.2. Japan
          • 5.2.4.2.3. India
          • 5.2.4.2.4. South Korea
          • 5.2.4.2.5. Taiwan
          • 5.2.4.2.6. Australia
          • 5.2.4.2.7. Rest of Asia-Pacific
        • 5.2.4.3. Europe
          • 5.2.4.3.1. Germany
          • 5.2.4.3.2. France
          • 5.2.4.3.3. Italy
          • 5.2.4.3.4. United Kingdom
          • 5.2.4.3.5. Netherlands
          • 5.2.4.3.6. Rest of Europe
        • 5.2.4.4. MEA
          • 5.2.4.4.1. Middle East
          • 5.2.4.4.2. Africa
        • 5.2.4.5. North America
          • 5.2.4.5.1. United States
          • 5.2.4.5.2. Canada
          • 5.2.4.5.3. Mexico
    • 5.3. Global IV Fluids (Volume)
      • 5.3.1. Global IV Fluids by: Type (Volume)
        • 5.3.1.1. Colloids
        • 5.3.1.2. Crystalloids
        • 5.3.1.3. Blood and blood products
        • 5.3.1.4. Oxygen-carrying solutions
      • 5.3.2. Global IV Fluids by: Composition (Volume)
        • 5.3.2.1. Normal Saline {0.9% Normal Saline (0.9% NaCl}
        • 5.3.2.2. Hypertonic saline {3, 5, & 7.5%}
        • 5.3.2.3. Lactated Ringer’s
        • 5.3.2.4. Dextran
        • 5.3.2.5. D5W {5% dextrose in water}
        • 5.3.2.6. Whole blood
        • 5.3.2.7. Platelets
        • 5.3.2.8. Others
      • 5.3.3. Global IV Fluids by: End User (Volume)
        • 5.3.3.1. Hospitals
        • 5.3.3.2. Clinics
        • 5.3.3.3. Ambulatory surgery centers
        • 5.3.3.4. Others
      • 5.3.4. Global IV Fluids Region
        • 5.3.4.1. South America
          • 5.3.4.1.1. Brazil
          • 5.3.4.1.2. Argentina
          • 5.3.4.1.3. Rest of South America
        • 5.3.4.2. Asia Pacific
          • 5.3.4.2.1. China
          • 5.3.4.2.2. Japan
          • 5.3.4.2.3. India
          • 5.3.4.2.4. South Korea
          • 5.3.4.2.5. Taiwan
          • 5.3.4.2.6. Australia
          • 5.3.4.2.7. Rest of Asia-Pacific
        • 5.3.4.3. Europe
          • 5.3.4.3.1. Germany
          • 5.3.4.3.2. France
          • 5.3.4.3.3. Italy
          • 5.3.4.3.4. United Kingdom
          • 5.3.4.3.5. Netherlands
          • 5.3.4.3.6. Rest of Europe
        • 5.3.4.4. MEA
          • 5.3.4.4.1. Middle East
          • 5.3.4.4.2. Africa
        • 5.3.4.5. North America
          • 5.3.4.5.1. United States
          • 5.3.4.5.2. Canada
          • 5.3.4.5.3. Mexico
    • 5.4. Global IV Fluids (Price)
      • 5.4.1. Global IV Fluids by: Type (Price)
  • 6. IV Fluids: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2023)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. B. Braun Melsungen AG (Germany)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Baxter (United Kingdom)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Fresenius Kabi AG (Germany)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Grifols (United States)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. ICU Medical, Inc. (United States)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Omnicare (United States)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. JW Life Science (South Korea)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Hospira Inc. (United States)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. Sichuan Kelun Pharmaceutical (China)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. Vifor Pharma (Switzerland)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
  • 7. Global IV Fluids Sale, by Type, Composition, End User and Region (value, volume and price ) (2025-2030)
    • 7.1. Introduction
    • 7.2. Global IV Fluids (Value)
      • 7.2.1. Global IV Fluids by: Type (Value)
        • 7.2.1.1. Colloids
        • 7.2.1.2. Crystalloids
        • 7.2.1.3. Blood and blood products
        • 7.2.1.4. Oxygen-carrying solutions
      • 7.2.2. Global IV Fluids by: Composition (Value)
        • 7.2.2.1. Normal Saline {0.9% Normal Saline (0.9% NaCl}
        • 7.2.2.2. Hypertonic saline {3, 5, & 7.5%}
        • 7.2.2.3. Lactated Ringer’s
        • 7.2.2.4. Dextran
        • 7.2.2.5. D5W {5% dextrose in water}
        • 7.2.2.6. Whole blood
        • 7.2.2.7. Platelets
        • 7.2.2.8. Others
      • 7.2.3. Global IV Fluids by: End User (Value)
        • 7.2.3.1. Hospitals
        • 7.2.3.2. Clinics
        • 7.2.3.3. Ambulatory surgery centers
        • 7.2.3.4. Others
      • 7.2.4. Global IV Fluids Region
        • 7.2.4.1. South America
          • 7.2.4.1.1. Brazil
          • 7.2.4.1.2. Argentina
          • 7.2.4.1.3. Rest of South America
        • 7.2.4.2. Asia Pacific
          • 7.2.4.2.1. China
          • 7.2.4.2.2. Japan
          • 7.2.4.2.3. India
          • 7.2.4.2.4. South Korea
          • 7.2.4.2.5. Taiwan
          • 7.2.4.2.6. Australia
          • 7.2.4.2.7. Rest of Asia-Pacific
        • 7.2.4.3. Europe
          • 7.2.4.3.1. Germany
          • 7.2.4.3.2. France
          • 7.2.4.3.3. Italy
          • 7.2.4.3.4. United Kingdom
          • 7.2.4.3.5. Netherlands
          • 7.2.4.3.6. Rest of Europe
        • 7.2.4.4. MEA
          • 7.2.4.4.1. Middle East
          • 7.2.4.4.2. Africa
        • 7.2.4.5. North America
          • 7.2.4.5.1. United States
          • 7.2.4.5.2. Canada
          • 7.2.4.5.3. Mexico
    • 7.3. Global IV Fluids (Volume)
      • 7.3.1. Global IV Fluids by: Type (Volume)
        • 7.3.1.1. Colloids
        • 7.3.1.2. Crystalloids
        • 7.3.1.3. Blood and blood products
        • 7.3.1.4. Oxygen-carrying solutions
      • 7.3.2. Global IV Fluids by: Composition (Volume)
        • 7.3.2.1. Normal Saline {0.9% Normal Saline (0.9% NaCl}
        • 7.3.2.2. Hypertonic saline {3, 5, & 7.5%}
        • 7.3.2.3. Lactated Ringer’s
        • 7.3.2.4. Dextran
        • 7.3.2.5. D5W {5% dextrose in water}
        • 7.3.2.6. Whole blood
        • 7.3.2.7. Platelets
        • 7.3.2.8. Others
      • 7.3.3. Global IV Fluids by: End User (Volume)
        • 7.3.3.1. Hospitals
        • 7.3.3.2. Clinics
        • 7.3.3.3. Ambulatory surgery centers
        • 7.3.3.4. Others
      • 7.3.4. Global IV Fluids Region
        • 7.3.4.1. South America
          • 7.3.4.1.1. Brazil
          • 7.3.4.1.2. Argentina
          • 7.3.4.1.3. Rest of South America
        • 7.3.4.2. Asia Pacific
          • 7.3.4.2.1. China
          • 7.3.4.2.2. Japan
          • 7.3.4.2.3. India
          • 7.3.4.2.4. South Korea
          • 7.3.4.2.5. Taiwan
          • 7.3.4.2.6. Australia
          • 7.3.4.2.7. Rest of Asia-Pacific
        • 7.3.4.3. Europe
          • 7.3.4.3.1. Germany
          • 7.3.4.3.2. France
          • 7.3.4.3.3. Italy
          • 7.3.4.3.4. United Kingdom
          • 7.3.4.3.5. Netherlands
          • 7.3.4.3.6. Rest of Europe
        • 7.3.4.4. MEA
          • 7.3.4.4.1. Middle East
          • 7.3.4.4.2. Africa
        • 7.3.4.5. North America
          • 7.3.4.5.1. United States
          • 7.3.4.5.2. Canada
          • 7.3.4.5.3. Mexico
    • 7.4. Global IV Fluids (Price)
      • 7.4.1. Global IV Fluids by: Type (Price)
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. IV Fluids: by Type(USD Million)
  • Table 2. IV Fluids Colloids , by Region USD Million (2018-2023)
  • Table 3. IV Fluids Crystalloids , by Region USD Million (2018-2023)
  • Table 4. IV Fluids Blood and blood products , by Region USD Million (2018-2023)
  • Table 5. IV Fluids Oxygen-carrying solutions , by Region USD Million (2018-2023)
  • Table 6. IV Fluids: by Composition(USD Million)
  • Table 7. IV Fluids Normal Saline {0.9% Normal Saline (0.9% NaCl} , by Region USD Million (2018-2023)
  • Table 8. IV Fluids Hypertonic saline {3, 5, & 7.5%} , by Region USD Million (2018-2023)
  • Table 9. IV Fluids Lactated Ringer’s , by Region USD Million (2018-2023)
  • Table 10. IV Fluids Dextran , by Region USD Million (2018-2023)
  • Table 11. IV Fluids D5W {5% dextrose in water} , by Region USD Million (2018-2023)
  • Table 12. IV Fluids Whole blood , by Region USD Million (2018-2023)
  • Table 13. IV Fluids Platelets , by Region USD Million (2018-2023)
  • Table 14. IV Fluids Others , by Region USD Million (2018-2023)
  • Table 15. IV Fluids: by End User(USD Million)
  • Table 16. IV Fluids Hospitals , by Region USD Million (2018-2023)
  • Table 17. IV Fluids Clinics , by Region USD Million (2018-2023)
  • Table 18. IV Fluids Ambulatory surgery centers , by Region USD Million (2018-2023)
  • Table 19. IV Fluids Others , by Region USD Million (2018-2023)
  • Table 20. South America IV Fluids, by Country USD Million (2018-2023)
  • Table 21. South America IV Fluids, by Type USD Million (2018-2023)
  • Table 22. South America IV Fluids, by Composition USD Million (2018-2023)
  • Table 23. South America IV Fluids, by End User USD Million (2018-2023)
  • Table 24. Brazil IV Fluids, by Type USD Million (2018-2023)
  • Table 25. Brazil IV Fluids, by Composition USD Million (2018-2023)
  • Table 26. Brazil IV Fluids, by End User USD Million (2018-2023)
  • Table 27. Argentina IV Fluids, by Type USD Million (2018-2023)
  • Table 28. Argentina IV Fluids, by Composition USD Million (2018-2023)
  • Table 29. Argentina IV Fluids, by End User USD Million (2018-2023)
  • Table 30. Rest of South America IV Fluids, by Type USD Million (2018-2023)
  • Table 31. Rest of South America IV Fluids, by Composition USD Million (2018-2023)
  • Table 32. Rest of South America IV Fluids, by End User USD Million (2018-2023)
  • Table 33. Asia Pacific IV Fluids, by Country USD Million (2018-2023)
  • Table 34. Asia Pacific IV Fluids, by Type USD Million (2018-2023)
  • Table 35. Asia Pacific IV Fluids, by Composition USD Million (2018-2023)
  • Table 36. Asia Pacific IV Fluids, by End User USD Million (2018-2023)
  • Table 37. China IV Fluids, by Type USD Million (2018-2023)
  • Table 38. China IV Fluids, by Composition USD Million (2018-2023)
  • Table 39. China IV Fluids, by End User USD Million (2018-2023)
  • Table 40. Japan IV Fluids, by Type USD Million (2018-2023)
  • Table 41. Japan IV Fluids, by Composition USD Million (2018-2023)
  • Table 42. Japan IV Fluids, by End User USD Million (2018-2023)
  • Table 43. India IV Fluids, by Type USD Million (2018-2023)
  • Table 44. India IV Fluids, by Composition USD Million (2018-2023)
  • Table 45. India IV Fluids, by End User USD Million (2018-2023)
  • Table 46. South Korea IV Fluids, by Type USD Million (2018-2023)
  • Table 47. South Korea IV Fluids, by Composition USD Million (2018-2023)
  • Table 48. South Korea IV Fluids, by End User USD Million (2018-2023)
  • Table 49. Taiwan IV Fluids, by Type USD Million (2018-2023)
  • Table 50. Taiwan IV Fluids, by Composition USD Million (2018-2023)
  • Table 51. Taiwan IV Fluids, by End User USD Million (2018-2023)
  • Table 52. Australia IV Fluids, by Type USD Million (2018-2023)
  • Table 53. Australia IV Fluids, by Composition USD Million (2018-2023)
  • Table 54. Australia IV Fluids, by End User USD Million (2018-2023)
  • Table 55. Rest of Asia-Pacific IV Fluids, by Type USD Million (2018-2023)
  • Table 56. Rest of Asia-Pacific IV Fluids, by Composition USD Million (2018-2023)
  • Table 57. Rest of Asia-Pacific IV Fluids, by End User USD Million (2018-2023)
  • Table 58. Europe IV Fluids, by Country USD Million (2018-2023)
  • Table 59. Europe IV Fluids, by Type USD Million (2018-2023)
  • Table 60. Europe IV Fluids, by Composition USD Million (2018-2023)
  • Table 61. Europe IV Fluids, by End User USD Million (2018-2023)
  • Table 62. Germany IV Fluids, by Type USD Million (2018-2023)
  • Table 63. Germany IV Fluids, by Composition USD Million (2018-2023)
  • Table 64. Germany IV Fluids, by End User USD Million (2018-2023)
  • Table 65. France IV Fluids, by Type USD Million (2018-2023)
  • Table 66. France IV Fluids, by Composition USD Million (2018-2023)
  • Table 67. France IV Fluids, by End User USD Million (2018-2023)
  • Table 68. Italy IV Fluids, by Type USD Million (2018-2023)
  • Table 69. Italy IV Fluids, by Composition USD Million (2018-2023)
  • Table 70. Italy IV Fluids, by End User USD Million (2018-2023)
  • Table 71. United Kingdom IV Fluids, by Type USD Million (2018-2023)
  • Table 72. United Kingdom IV Fluids, by Composition USD Million (2018-2023)
  • Table 73. United Kingdom IV Fluids, by End User USD Million (2018-2023)
  • Table 74. Netherlands IV Fluids, by Type USD Million (2018-2023)
  • Table 75. Netherlands IV Fluids, by Composition USD Million (2018-2023)
  • Table 76. Netherlands IV Fluids, by End User USD Million (2018-2023)
  • Table 77. Rest of Europe IV Fluids, by Type USD Million (2018-2023)
  • Table 78. Rest of Europe IV Fluids, by Composition USD Million (2018-2023)
  • Table 79. Rest of Europe IV Fluids, by End User USD Million (2018-2023)
  • Table 80. MEA IV Fluids, by Country USD Million (2018-2023)
  • Table 81. MEA IV Fluids, by Type USD Million (2018-2023)
  • Table 82. MEA IV Fluids, by Composition USD Million (2018-2023)
  • Table 83. MEA IV Fluids, by End User USD Million (2018-2023)
  • Table 84. Middle East IV Fluids, by Type USD Million (2018-2023)
  • Table 85. Middle East IV Fluids, by Composition USD Million (2018-2023)
  • Table 86. Middle East IV Fluids, by End User USD Million (2018-2023)
  • Table 87. Africa IV Fluids, by Type USD Million (2018-2023)
  • Table 88. Africa IV Fluids, by Composition USD Million (2018-2023)
  • Table 89. Africa IV Fluids, by End User USD Million (2018-2023)
  • Table 90. North America IV Fluids, by Country USD Million (2018-2023)
  • Table 91. North America IV Fluids, by Type USD Million (2018-2023)
  • Table 92. North America IV Fluids, by Composition USD Million (2018-2023)
  • Table 93. North America IV Fluids, by End User USD Million (2018-2023)
  • Table 94. United States IV Fluids, by Type USD Million (2018-2023)
  • Table 95. United States IV Fluids, by Composition USD Million (2018-2023)
  • Table 96. United States IV Fluids, by End User USD Million (2018-2023)
  • Table 97. Canada IV Fluids, by Type USD Million (2018-2023)
  • Table 98. Canada IV Fluids, by Composition USD Million (2018-2023)
  • Table 99. Canada IV Fluids, by End User USD Million (2018-2023)
  • Table 100. Mexico IV Fluids, by Type USD Million (2018-2023)
  • Table 101. Mexico IV Fluids, by Composition USD Million (2018-2023)
  • Table 102. Mexico IV Fluids, by End User USD Million (2018-2023)
  • Table 103. IV Fluids Sales: by Type(K Liters)
  • Table 104. IV Fluids Sales Colloids , by Region K Liters (2018-2023)
  • Table 105. IV Fluids Sales Crystalloids , by Region K Liters (2018-2023)
  • Table 106. IV Fluids Sales Blood and blood products , by Region K Liters (2018-2023)
  • Table 107. IV Fluids Sales Oxygen-carrying solutions , by Region K Liters (2018-2023)
  • Table 108. IV Fluids Sales: by Composition(K Liters)
  • Table 109. IV Fluids Sales Normal Saline {0.9% Normal Saline (0.9% NaCl} , by Region K Liters (2018-2023)
  • Table 110. IV Fluids Sales Hypertonic saline {3, 5, & 7.5%} , by Region K Liters (2018-2023)
  • Table 111. IV Fluids Sales Lactated Ringer’s , by Region K Liters (2018-2023)
  • Table 112. IV Fluids Sales Dextran , by Region K Liters (2018-2023)
  • Table 113. IV Fluids Sales D5W {5% dextrose in water} , by Region K Liters (2018-2023)
  • Table 114. IV Fluids Sales Whole blood , by Region K Liters (2018-2023)
  • Table 115. IV Fluids Sales Platelets , by Region K Liters (2018-2023)
  • Table 116. IV Fluids Sales Others , by Region K Liters (2018-2023)
  • Table 117. IV Fluids Sales: by End User(K Liters)
  • Table 118. IV Fluids Sales Hospitals , by Region K Liters (2018-2023)
  • Table 119. IV Fluids Sales Clinics , by Region K Liters (2018-2023)
  • Table 120. IV Fluids Sales Ambulatory surgery centers , by Region K Liters (2018-2023)
  • Table 121. IV Fluids Sales Others , by Region K Liters (2018-2023)
  • Table 122. South America IV Fluids Sales, by Country K Liters (2018-2023)
  • Table 123. South America IV Fluids Sales, by Type K Liters (2018-2023)
  • Table 124. South America IV Fluids Sales, by Composition K Liters (2018-2023)
  • Table 125. South America IV Fluids Sales, by End User K Liters (2018-2023)
  • Table 126. Brazil IV Fluids Sales, by Type K Liters (2018-2023)
  • Table 127. Brazil IV Fluids Sales, by Composition K Liters (2018-2023)
  • Table 128. Brazil IV Fluids Sales, by End User K Liters (2018-2023)
  • Table 129. Argentina IV Fluids Sales, by Type K Liters (2018-2023)
  • Table 130. Argentina IV Fluids Sales, by Composition K Liters (2018-2023)
  • Table 131. Argentina IV Fluids Sales, by End User K Liters (2018-2023)
  • Table 132. Rest of South America IV Fluids Sales, by Type K Liters (2018-2023)
  • Table 133. Rest of South America IV Fluids Sales, by Composition K Liters (2018-2023)
  • Table 134. Rest of South America IV Fluids Sales, by End User K Liters (2018-2023)
  • Table 135. Asia Pacific IV Fluids Sales, by Country K Liters (2018-2023)
  • Table 136. Asia Pacific IV Fluids Sales, by Type K Liters (2018-2023)
  • Table 137. Asia Pacific IV Fluids Sales, by Composition K Liters (2018-2023)
  • Table 138. Asia Pacific IV Fluids Sales, by End User K Liters (2018-2023)
  • Table 139. China IV Fluids Sales, by Type K Liters (2018-2023)
  • Table 140. China IV Fluids Sales, by Composition K Liters (2018-2023)
  • Table 141. China IV Fluids Sales, by End User K Liters (2018-2023)
  • Table 142. Japan IV Fluids Sales, by Type K Liters (2018-2023)
  • Table 143. Japan IV Fluids Sales, by Composition K Liters (2018-2023)
  • Table 144. Japan IV Fluids Sales, by End User K Liters (2018-2023)
  • Table 145. India IV Fluids Sales, by Type K Liters (2018-2023)
  • Table 146. India IV Fluids Sales, by Composition K Liters (2018-2023)
  • Table 147. India IV Fluids Sales, by End User K Liters (2018-2023)
  • Table 148. South Korea IV Fluids Sales, by Type K Liters (2018-2023)
  • Table 149. South Korea IV Fluids Sales, by Composition K Liters (2018-2023)
  • Table 150. South Korea IV Fluids Sales, by End User K Liters (2018-2023)
  • Table 151. Taiwan IV Fluids Sales, by Type K Liters (2018-2023)
  • Table 152. Taiwan IV Fluids Sales, by Composition K Liters (2018-2023)
  • Table 153. Taiwan IV Fluids Sales, by End User K Liters (2018-2023)
  • Table 154. Australia IV Fluids Sales, by Type K Liters (2018-2023)
  • Table 155. Australia IV Fluids Sales, by Composition K Liters (2018-2023)
  • Table 156. Australia IV Fluids Sales, by End User K Liters (2018-2023)
  • Table 157. Rest of Asia-Pacific IV Fluids Sales, by Type K Liters (2018-2023)
  • Table 158. Rest of Asia-Pacific IV Fluids Sales, by Composition K Liters (2018-2023)
  • Table 159. Rest of Asia-Pacific IV Fluids Sales, by End User K Liters (2018-2023)
  • Table 160. Europe IV Fluids Sales, by Country K Liters (2018-2023)
  • Table 161. Europe IV Fluids Sales, by Type K Liters (2018-2023)
  • Table 162. Europe IV Fluids Sales, by Composition K Liters (2018-2023)
  • Table 163. Europe IV Fluids Sales, by End User K Liters (2018-2023)
  • Table 164. Germany IV Fluids Sales, by Type K Liters (2018-2023)
  • Table 165. Germany IV Fluids Sales, by Composition K Liters (2018-2023)
  • Table 166. Germany IV Fluids Sales, by End User K Liters (2018-2023)
  • Table 167. France IV Fluids Sales, by Type K Liters (2018-2023)
  • Table 168. France IV Fluids Sales, by Composition K Liters (2018-2023)
  • Table 169. France IV Fluids Sales, by End User K Liters (2018-2023)
  • Table 170. Italy IV Fluids Sales, by Type K Liters (2018-2023)
  • Table 171. Italy IV Fluids Sales, by Composition K Liters (2018-2023)
  • Table 172. Italy IV Fluids Sales, by End User K Liters (2018-2023)
  • Table 173. United Kingdom IV Fluids Sales, by Type K Liters (2018-2023)
  • Table 174. United Kingdom IV Fluids Sales, by Composition K Liters (2018-2023)
  • Table 175. United Kingdom IV Fluids Sales, by End User K Liters (2018-2023)
  • Table 176. Netherlands IV Fluids Sales, by Type K Liters (2018-2023)
  • Table 177. Netherlands IV Fluids Sales, by Composition K Liters (2018-2023)
  • Table 178. Netherlands IV Fluids Sales, by End User K Liters (2018-2023)
  • Table 179. Rest of Europe IV Fluids Sales, by Type K Liters (2018-2023)
  • Table 180. Rest of Europe IV Fluids Sales, by Composition K Liters (2018-2023)
  • Table 181. Rest of Europe IV Fluids Sales, by End User K Liters (2018-2023)
  • Table 182. MEA IV Fluids Sales, by Country K Liters (2018-2023)
  • Table 183. MEA IV Fluids Sales, by Type K Liters (2018-2023)
  • Table 184. MEA IV Fluids Sales, by Composition K Liters (2018-2023)
  • Table 185. MEA IV Fluids Sales, by End User K Liters (2018-2023)
  • Table 186. Middle East IV Fluids Sales, by Type K Liters (2018-2023)
  • Table 187. Middle East IV Fluids Sales, by Composition K Liters (2018-2023)
  • Table 188. Middle East IV Fluids Sales, by End User K Liters (2018-2023)
  • Table 189. Africa IV Fluids Sales, by Type K Liters (2018-2023)
  • Table 190. Africa IV Fluids Sales, by Composition K Liters (2018-2023)
  • Table 191. Africa IV Fluids Sales, by End User K Liters (2018-2023)
  • Table 192. North America IV Fluids Sales, by Country K Liters (2018-2023)
  • Table 193. North America IV Fluids Sales, by Type K Liters (2018-2023)
  • Table 194. North America IV Fluids Sales, by Composition K Liters (2018-2023)
  • Table 195. North America IV Fluids Sales, by End User K Liters (2018-2023)
  • Table 196. United States IV Fluids Sales, by Type K Liters (2018-2023)
  • Table 197. United States IV Fluids Sales, by Composition K Liters (2018-2023)
  • Table 198. United States IV Fluids Sales, by End User K Liters (2018-2023)
  • Table 199. Canada IV Fluids Sales, by Type K Liters (2018-2023)
  • Table 200. Canada IV Fluids Sales, by Composition K Liters (2018-2023)
  • Table 201. Canada IV Fluids Sales, by End User K Liters (2018-2023)
  • Table 202. Mexico IV Fluids Sales, by Type K Liters (2018-2023)
  • Table 203. Mexico IV Fluids Sales, by Composition K Liters (2018-2023)
  • Table 204. Mexico IV Fluids Sales, by End User K Liters (2018-2023)
  • Table 205. IV Fluids: by Type(USD/Units)
  • Table 206. Company Basic Information, Sales Area and Its Competitors
  • Table 207. Company Basic Information, Sales Area and Its Competitors
  • Table 208. Company Basic Information, Sales Area and Its Competitors
  • Table 209. Company Basic Information, Sales Area and Its Competitors
  • Table 210. Company Basic Information, Sales Area and Its Competitors
  • Table 211. Company Basic Information, Sales Area and Its Competitors
  • Table 212. Company Basic Information, Sales Area and Its Competitors
  • Table 213. Company Basic Information, Sales Area and Its Competitors
  • Table 214. Company Basic Information, Sales Area and Its Competitors
  • Table 215. Company Basic Information, Sales Area and Its Competitors
  • Table 216. IV Fluids: by Type(USD Million)
  • Table 217. IV Fluids Colloids , by Region USD Million (2025-2030)
  • Table 218. IV Fluids Crystalloids , by Region USD Million (2025-2030)
  • Table 219. IV Fluids Blood and blood products , by Region USD Million (2025-2030)
  • Table 220. IV Fluids Oxygen-carrying solutions , by Region USD Million (2025-2030)
  • Table 221. IV Fluids: by Composition(USD Million)
  • Table 222. IV Fluids Normal Saline {0.9% Normal Saline (0.9% NaCl} , by Region USD Million (2025-2030)
  • Table 223. IV Fluids Hypertonic saline {3, 5, & 7.5%} , by Region USD Million (2025-2030)
  • Table 224. IV Fluids Lactated Ringer’s , by Region USD Million (2025-2030)
  • Table 225. IV Fluids Dextran , by Region USD Million (2025-2030)
  • Table 226. IV Fluids D5W {5% dextrose in water} , by Region USD Million (2025-2030)
  • Table 227. IV Fluids Whole blood , by Region USD Million (2025-2030)
  • Table 228. IV Fluids Platelets , by Region USD Million (2025-2030)
  • Table 229. IV Fluids Others , by Region USD Million (2025-2030)
  • Table 230. IV Fluids: by End User(USD Million)
  • Table 231. IV Fluids Hospitals , by Region USD Million (2025-2030)
  • Table 232. IV Fluids Clinics , by Region USD Million (2025-2030)
  • Table 233. IV Fluids Ambulatory surgery centers , by Region USD Million (2025-2030)
  • Table 234. IV Fluids Others , by Region USD Million (2025-2030)
  • Table 235. South America IV Fluids, by Country USD Million (2025-2030)
  • Table 236. South America IV Fluids, by Type USD Million (2025-2030)
  • Table 237. South America IV Fluids, by Composition USD Million (2025-2030)
  • Table 238. South America IV Fluids, by End User USD Million (2025-2030)
  • Table 239. Brazil IV Fluids, by Type USD Million (2025-2030)
  • Table 240. Brazil IV Fluids, by Composition USD Million (2025-2030)
  • Table 241. Brazil IV Fluids, by End User USD Million (2025-2030)
  • Table 242. Argentina IV Fluids, by Type USD Million (2025-2030)
  • Table 243. Argentina IV Fluids, by Composition USD Million (2025-2030)
  • Table 244. Argentina IV Fluids, by End User USD Million (2025-2030)
  • Table 245. Rest of South America IV Fluids, by Type USD Million (2025-2030)
  • Table 246. Rest of South America IV Fluids, by Composition USD Million (2025-2030)
  • Table 247. Rest of South America IV Fluids, by End User USD Million (2025-2030)
  • Table 248. Asia Pacific IV Fluids, by Country USD Million (2025-2030)
  • Table 249. Asia Pacific IV Fluids, by Type USD Million (2025-2030)
  • Table 250. Asia Pacific IV Fluids, by Composition USD Million (2025-2030)
  • Table 251. Asia Pacific IV Fluids, by End User USD Million (2025-2030)
  • Table 252. China IV Fluids, by Type USD Million (2025-2030)
  • Table 253. China IV Fluids, by Composition USD Million (2025-2030)
  • Table 254. China IV Fluids, by End User USD Million (2025-2030)
  • Table 255. Japan IV Fluids, by Type USD Million (2025-2030)
  • Table 256. Japan IV Fluids, by Composition USD Million (2025-2030)
  • Table 257. Japan IV Fluids, by End User USD Million (2025-2030)
  • Table 258. India IV Fluids, by Type USD Million (2025-2030)
  • Table 259. India IV Fluids, by Composition USD Million (2025-2030)
  • Table 260. India IV Fluids, by End User USD Million (2025-2030)
  • Table 261. South Korea IV Fluids, by Type USD Million (2025-2030)
  • Table 262. South Korea IV Fluids, by Composition USD Million (2025-2030)
  • Table 263. South Korea IV Fluids, by End User USD Million (2025-2030)
  • Table 264. Taiwan IV Fluids, by Type USD Million (2025-2030)
  • Table 265. Taiwan IV Fluids, by Composition USD Million (2025-2030)
  • Table 266. Taiwan IV Fluids, by End User USD Million (2025-2030)
  • Table 267. Australia IV Fluids, by Type USD Million (2025-2030)
  • Table 268. Australia IV Fluids, by Composition USD Million (2025-2030)
  • Table 269. Australia IV Fluids, by End User USD Million (2025-2030)
  • Table 270. Rest of Asia-Pacific IV Fluids, by Type USD Million (2025-2030)
  • Table 271. Rest of Asia-Pacific IV Fluids, by Composition USD Million (2025-2030)
  • Table 272. Rest of Asia-Pacific IV Fluids, by End User USD Million (2025-2030)
  • Table 273. Europe IV Fluids, by Country USD Million (2025-2030)
  • Table 274. Europe IV Fluids, by Type USD Million (2025-2030)
  • Table 275. Europe IV Fluids, by Composition USD Million (2025-2030)
  • Table 276. Europe IV Fluids, by End User USD Million (2025-2030)
  • Table 277. Germany IV Fluids, by Type USD Million (2025-2030)
  • Table 278. Germany IV Fluids, by Composition USD Million (2025-2030)
  • Table 279. Germany IV Fluids, by End User USD Million (2025-2030)
  • Table 280. France IV Fluids, by Type USD Million (2025-2030)
  • Table 281. France IV Fluids, by Composition USD Million (2025-2030)
  • Table 282. France IV Fluids, by End User USD Million (2025-2030)
  • Table 283. Italy IV Fluids, by Type USD Million (2025-2030)
  • Table 284. Italy IV Fluids, by Composition USD Million (2025-2030)
  • Table 285. Italy IV Fluids, by End User USD Million (2025-2030)
  • Table 286. United Kingdom IV Fluids, by Type USD Million (2025-2030)
  • Table 287. United Kingdom IV Fluids, by Composition USD Million (2025-2030)
  • Table 288. United Kingdom IV Fluids, by End User USD Million (2025-2030)
  • Table 289. Netherlands IV Fluids, by Type USD Million (2025-2030)
  • Table 290. Netherlands IV Fluids, by Composition USD Million (2025-2030)
  • Table 291. Netherlands IV Fluids, by End User USD Million (2025-2030)
  • Table 292. Rest of Europe IV Fluids, by Type USD Million (2025-2030)
  • Table 293. Rest of Europe IV Fluids, by Composition USD Million (2025-2030)
  • Table 294. Rest of Europe IV Fluids, by End User USD Million (2025-2030)
  • Table 295. MEA IV Fluids, by Country USD Million (2025-2030)
  • Table 296. MEA IV Fluids, by Type USD Million (2025-2030)
  • Table 297. MEA IV Fluids, by Composition USD Million (2025-2030)
  • Table 298. MEA IV Fluids, by End User USD Million (2025-2030)
  • Table 299. Middle East IV Fluids, by Type USD Million (2025-2030)
  • Table 300. Middle East IV Fluids, by Composition USD Million (2025-2030)
  • Table 301. Middle East IV Fluids, by End User USD Million (2025-2030)
  • Table 302. Africa IV Fluids, by Type USD Million (2025-2030)
  • Table 303. Africa IV Fluids, by Composition USD Million (2025-2030)
  • Table 304. Africa IV Fluids, by End User USD Million (2025-2030)
  • Table 305. North America IV Fluids, by Country USD Million (2025-2030)
  • Table 306. North America IV Fluids, by Type USD Million (2025-2030)
  • Table 307. North America IV Fluids, by Composition USD Million (2025-2030)
  • Table 308. North America IV Fluids, by End User USD Million (2025-2030)
  • Table 309. United States IV Fluids, by Type USD Million (2025-2030)
  • Table 310. United States IV Fluids, by Composition USD Million (2025-2030)
  • Table 311. United States IV Fluids, by End User USD Million (2025-2030)
  • Table 312. Canada IV Fluids, by Type USD Million (2025-2030)
  • Table 313. Canada IV Fluids, by Composition USD Million (2025-2030)
  • Table 314. Canada IV Fluids, by End User USD Million (2025-2030)
  • Table 315. Mexico IV Fluids, by Type USD Million (2025-2030)
  • Table 316. Mexico IV Fluids, by Composition USD Million (2025-2030)
  • Table 317. Mexico IV Fluids, by End User USD Million (2025-2030)
  • Table 318. IV Fluids Sales: by Type(K Liters)
  • Table 319. IV Fluids Sales Colloids , by Region K Liters (2025-2030)
  • Table 320. IV Fluids Sales Crystalloids , by Region K Liters (2025-2030)
  • Table 321. IV Fluids Sales Blood and blood products , by Region K Liters (2025-2030)
  • Table 322. IV Fluids Sales Oxygen-carrying solutions , by Region K Liters (2025-2030)
  • Table 323. IV Fluids Sales: by Composition(K Liters)
  • Table 324. IV Fluids Sales Normal Saline {0.9% Normal Saline (0.9% NaCl} , by Region K Liters (2025-2030)
  • Table 325. IV Fluids Sales Hypertonic saline {3, 5, & 7.5%} , by Region K Liters (2025-2030)
  • Table 326. IV Fluids Sales Lactated Ringer’s , by Region K Liters (2025-2030)
  • Table 327. IV Fluids Sales Dextran , by Region K Liters (2025-2030)
  • Table 328. IV Fluids Sales D5W {5% dextrose in water} , by Region K Liters (2025-2030)
  • Table 329. IV Fluids Sales Whole blood , by Region K Liters (2025-2030)
  • Table 330. IV Fluids Sales Platelets , by Region K Liters (2025-2030)
  • Table 331. IV Fluids Sales Others , by Region K Liters (2025-2030)
  • Table 332. IV Fluids Sales: by End User(K Liters)
  • Table 333. IV Fluids Sales Hospitals , by Region K Liters (2025-2030)
  • Table 334. IV Fluids Sales Clinics , by Region K Liters (2025-2030)
  • Table 335. IV Fluids Sales Ambulatory surgery centers , by Region K Liters (2025-2030)
  • Table 336. IV Fluids Sales Others , by Region K Liters (2025-2030)
  • Table 337. South America IV Fluids Sales, by Country K Liters (2025-2030)
  • Table 338. South America IV Fluids Sales, by Type K Liters (2025-2030)
  • Table 339. South America IV Fluids Sales, by Composition K Liters (2025-2030)
  • Table 340. South America IV Fluids Sales, by End User K Liters (2025-2030)
  • Table 341. Brazil IV Fluids Sales, by Type K Liters (2025-2030)
  • Table 342. Brazil IV Fluids Sales, by Composition K Liters (2025-2030)
  • Table 343. Brazil IV Fluids Sales, by End User K Liters (2025-2030)
  • Table 344. Argentina IV Fluids Sales, by Type K Liters (2025-2030)
  • Table 345. Argentina IV Fluids Sales, by Composition K Liters (2025-2030)
  • Table 346. Argentina IV Fluids Sales, by End User K Liters (2025-2030)
  • Table 347. Rest of South America IV Fluids Sales, by Type K Liters (2025-2030)
  • Table 348. Rest of South America IV Fluids Sales, by Composition K Liters (2025-2030)
  • Table 349. Rest of South America IV Fluids Sales, by End User K Liters (2025-2030)
  • Table 350. Asia Pacific IV Fluids Sales, by Country K Liters (2025-2030)
  • Table 351. Asia Pacific IV Fluids Sales, by Type K Liters (2025-2030)
  • Table 352. Asia Pacific IV Fluids Sales, by Composition K Liters (2025-2030)
  • Table 353. Asia Pacific IV Fluids Sales, by End User K Liters (2025-2030)
  • Table 354. China IV Fluids Sales, by Type K Liters (2025-2030)
  • Table 355. China IV Fluids Sales, by Composition K Liters (2025-2030)
  • Table 356. China IV Fluids Sales, by End User K Liters (2025-2030)
  • Table 357. Japan IV Fluids Sales, by Type K Liters (2025-2030)
  • Table 358. Japan IV Fluids Sales, by Composition K Liters (2025-2030)
  • Table 359. Japan IV Fluids Sales, by End User K Liters (2025-2030)
  • Table 360. India IV Fluids Sales, by Type K Liters (2025-2030)
  • Table 361. India IV Fluids Sales, by Composition K Liters (2025-2030)
  • Table 362. India IV Fluids Sales, by End User K Liters (2025-2030)
  • Table 363. South Korea IV Fluids Sales, by Type K Liters (2025-2030)
  • Table 364. South Korea IV Fluids Sales, by Composition K Liters (2025-2030)
  • Table 365. South Korea IV Fluids Sales, by End User K Liters (2025-2030)
  • Table 366. Taiwan IV Fluids Sales, by Type K Liters (2025-2030)
  • Table 367. Taiwan IV Fluids Sales, by Composition K Liters (2025-2030)
  • Table 368. Taiwan IV Fluids Sales, by End User K Liters (2025-2030)
  • Table 369. Australia IV Fluids Sales, by Type K Liters (2025-2030)
  • Table 370. Australia IV Fluids Sales, by Composition K Liters (2025-2030)
  • Table 371. Australia IV Fluids Sales, by End User K Liters (2025-2030)
  • Table 372. Rest of Asia-Pacific IV Fluids Sales, by Type K Liters (2025-2030)
  • Table 373. Rest of Asia-Pacific IV Fluids Sales, by Composition K Liters (2025-2030)
  • Table 374. Rest of Asia-Pacific IV Fluids Sales, by End User K Liters (2025-2030)
  • Table 375. Europe IV Fluids Sales, by Country K Liters (2025-2030)
  • Table 376. Europe IV Fluids Sales, by Type K Liters (2025-2030)
  • Table 377. Europe IV Fluids Sales, by Composition K Liters (2025-2030)
  • Table 378. Europe IV Fluids Sales, by End User K Liters (2025-2030)
  • Table 379. Germany IV Fluids Sales, by Type K Liters (2025-2030)
  • Table 380. Germany IV Fluids Sales, by Composition K Liters (2025-2030)
  • Table 381. Germany IV Fluids Sales, by End User K Liters (2025-2030)
  • Table 382. France IV Fluids Sales, by Type K Liters (2025-2030)
  • Table 383. France IV Fluids Sales, by Composition K Liters (2025-2030)
  • Table 384. France IV Fluids Sales, by End User K Liters (2025-2030)
  • Table 385. Italy IV Fluids Sales, by Type K Liters (2025-2030)
  • Table 386. Italy IV Fluids Sales, by Composition K Liters (2025-2030)
  • Table 387. Italy IV Fluids Sales, by End User K Liters (2025-2030)
  • Table 388. United Kingdom IV Fluids Sales, by Type K Liters (2025-2030)
  • Table 389. United Kingdom IV Fluids Sales, by Composition K Liters (2025-2030)
  • Table 390. United Kingdom IV Fluids Sales, by End User K Liters (2025-2030)
  • Table 391. Netherlands IV Fluids Sales, by Type K Liters (2025-2030)
  • Table 392. Netherlands IV Fluids Sales, by Composition K Liters (2025-2030)
  • Table 393. Netherlands IV Fluids Sales, by End User K Liters (2025-2030)
  • Table 394. Rest of Europe IV Fluids Sales, by Type K Liters (2025-2030)
  • Table 395. Rest of Europe IV Fluids Sales, by Composition K Liters (2025-2030)
  • Table 396. Rest of Europe IV Fluids Sales, by End User K Liters (2025-2030)
  • Table 397. MEA IV Fluids Sales, by Country K Liters (2025-2030)
  • Table 398. MEA IV Fluids Sales, by Type K Liters (2025-2030)
  • Table 399. MEA IV Fluids Sales, by Composition K Liters (2025-2030)
  • Table 400. MEA IV Fluids Sales, by End User K Liters (2025-2030)
  • Table 401. Middle East IV Fluids Sales, by Type K Liters (2025-2030)
  • Table 402. Middle East IV Fluids Sales, by Composition K Liters (2025-2030)
  • Table 403. Middle East IV Fluids Sales, by End User K Liters (2025-2030)
  • Table 404. Africa IV Fluids Sales, by Type K Liters (2025-2030)
  • Table 405. Africa IV Fluids Sales, by Composition K Liters (2025-2030)
  • Table 406. Africa IV Fluids Sales, by End User K Liters (2025-2030)
  • Table 407. North America IV Fluids Sales, by Country K Liters (2025-2030)
  • Table 408. North America IV Fluids Sales, by Type K Liters (2025-2030)
  • Table 409. North America IV Fluids Sales, by Composition K Liters (2025-2030)
  • Table 410. North America IV Fluids Sales, by End User K Liters (2025-2030)
  • Table 411. United States IV Fluids Sales, by Type K Liters (2025-2030)
  • Table 412. United States IV Fluids Sales, by Composition K Liters (2025-2030)
  • Table 413. United States IV Fluids Sales, by End User K Liters (2025-2030)
  • Table 414. Canada IV Fluids Sales, by Type K Liters (2025-2030)
  • Table 415. Canada IV Fluids Sales, by Composition K Liters (2025-2030)
  • Table 416. Canada IV Fluids Sales, by End User K Liters (2025-2030)
  • Table 417. Mexico IV Fluids Sales, by Type K Liters (2025-2030)
  • Table 418. Mexico IV Fluids Sales, by Composition K Liters (2025-2030)
  • Table 419. Mexico IV Fluids Sales, by End User K Liters (2025-2030)
  • Table 420. IV Fluids: by Type(USD/Units)
  • Table 421. Research Programs/Design for This Report
  • Table 422. Key Data Information from Secondary Sources
  • Table 423. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global IV Fluids: by Type USD Million (2018-2023)
  • Figure 5. Global IV Fluids: by Composition USD Million (2018-2023)
  • Figure 6. Global IV Fluids: by End User USD Million (2018-2023)
  • Figure 7. South America IV Fluids Share (%), by Country
  • Figure 8. Asia Pacific IV Fluids Share (%), by Country
  • Figure 9. Europe IV Fluids Share (%), by Country
  • Figure 10. MEA IV Fluids Share (%), by Country
  • Figure 11. North America IV Fluids Share (%), by Country
  • Figure 12. Global IV Fluids: by Type K Liters (2018-2023)
  • Figure 13. Global IV Fluids: by Composition K Liters (2018-2023)
  • Figure 14. Global IV Fluids: by End User K Liters (2018-2023)
  • Figure 15. South America IV Fluids Share (%), by Country
  • Figure 16. Asia Pacific IV Fluids Share (%), by Country
  • Figure 17. Europe IV Fluids Share (%), by Country
  • Figure 18. MEA IV Fluids Share (%), by Country
  • Figure 19. North America IV Fluids Share (%), by Country
  • Figure 20. Global IV Fluids: by Type USD/Units (2018-2023)
  • Figure 21. Global IV Fluids share by Players 2023 (%)
  • Figure 22. Global IV Fluids share by Players (Top 3) 2023(%)
  • Figure 23. Global IV Fluids share by Players (Top 5) 2023(%)
  • Figure 24. BCG Matrix for key Companies
  • Figure 25. B. Braun Melsungen AG (Germany) Revenue, Net Income and Gross profit
  • Figure 26. B. Braun Melsungen AG (Germany) Revenue: by Geography 2023
  • Figure 27. Baxter (United Kingdom) Revenue, Net Income and Gross profit
  • Figure 28. Baxter (United Kingdom) Revenue: by Geography 2023
  • Figure 29. Fresenius Kabi AG (Germany) Revenue, Net Income and Gross profit
  • Figure 30. Fresenius Kabi AG (Germany) Revenue: by Geography 2023
  • Figure 31. Grifols (United States) Revenue, Net Income and Gross profit
  • Figure 32. Grifols (United States) Revenue: by Geography 2023
  • Figure 33. ICU Medical, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 34. ICU Medical, Inc. (United States) Revenue: by Geography 2023
  • Figure 35. Omnicare (United States) Revenue, Net Income and Gross profit
  • Figure 36. Omnicare (United States) Revenue: by Geography 2023
  • Figure 37. JW Life Science (South Korea) Revenue, Net Income and Gross profit
  • Figure 38. JW Life Science (South Korea) Revenue: by Geography 2023
  • Figure 39. Hospira Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 40. Hospira Inc. (United States) Revenue: by Geography 2023
  • Figure 41. Sichuan Kelun Pharmaceutical (China) Revenue, Net Income and Gross profit
  • Figure 42. Sichuan Kelun Pharmaceutical (China) Revenue: by Geography 2023
  • Figure 43. Vifor Pharma (Switzerland) Revenue, Net Income and Gross profit
  • Figure 44. Vifor Pharma (Switzerland) Revenue: by Geography 2023
  • Figure 45. Global IV Fluids: by Type USD Million (2025-2030)
  • Figure 46. Global IV Fluids: by Composition USD Million (2025-2030)
  • Figure 47. Global IV Fluids: by End User USD Million (2025-2030)
  • Figure 48. South America IV Fluids Share (%), by Country
  • Figure 49. Asia Pacific IV Fluids Share (%), by Country
  • Figure 50. Europe IV Fluids Share (%), by Country
  • Figure 51. MEA IV Fluids Share (%), by Country
  • Figure 52. North America IV Fluids Share (%), by Country
  • Figure 53. Global IV Fluids: by Type K Liters (2025-2030)
  • Figure 54. Global IV Fluids: by Composition K Liters (2025-2030)
  • Figure 55. Global IV Fluids: by End User K Liters (2025-2030)
  • Figure 56. South America IV Fluids Share (%), by Country
  • Figure 57. Asia Pacific IV Fluids Share (%), by Country
  • Figure 58. Europe IV Fluids Share (%), by Country
  • Figure 59. MEA IV Fluids Share (%), by Country
  • Figure 60. North America IV Fluids Share (%), by Country
  • Figure 61. Global IV Fluids: by Type USD/Units (2025-2030)
List of companies from research coverage that are profiled in the study
  • B. Braun Melsungen AG (Germany)
  • Baxter (United Kingdom)
  • Fresenius Kabi AG (Germany)
  • Grifols (United States)
  • ICU Medical, Inc. (United States)
  • Omnicare (United States)
  • JW Life Science (South Korea)
  • Hospira Inc. (United States)
  • Sichuan Kelun Pharmaceutical (China)
  • Vifor Pharma (Switzerland)
Additional players considered in the study are as follows:
Fresenius Kabi (Germany) , Claris Lifesciences (India)
Select User Access Type

Key Highlights of Report


Mar 2024 157 Pages 72 Tables Base Year: 2023 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Global IV Fluids Market Quantitative research analysis
Global IV Fluids Market Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

The standard version of the report profiles players such as B. Braun Melsungen AG (Germany), Baxter (United Kingdom), Fresenius Kabi AG (Germany), Grifols (United States), ICU Medical, Inc. (United States), Omnicare (United States), JW Life Science (South Korea), Hospira Inc. (United States), Sichuan Kelun Pharmaceutical (China) and Vifor Pharma (Switzerland) etc.
The Study can be customized subject to feasibility and data availability. Please connect with our sales representative for further information.
"" is seen as one of major influencing trends for IV Fluids Market during projected period 2023-2030.
The IV Fluids market study includes a random mix of players, including both market leaders and some top growing emerging players. Connect with our sales executive to get a complete company list in our research coverage.

Know More About Global IV Fluids Market Report?

Have a Query? Click Here

Other Related Reports

Nelarabine Comprehensive Study by Application (Pregnancy, Nursing Mothers, Pediatric Use, Geriatric Use, Renal Impairment, Hepatic Impairment, Others), Distribution Channel (Online Channels, Offline ...
$ 3650
Degarelix Comprehensive Study by Type (120 mg per vial, 80 mg per vial), Application (Hospital, Drug store), Distribution Channel (Online, Offline) Players and Region - Global Market Outlook to 2028
$ 3500
Molecular Quality Controls Comprehensive Study by Type (Independent, Instrument Specific (DNA Sequencing)), Application (Infectious Diseases, Oncology, Genetic Tests, Other), End Users (IVD Manufactu...
$ 3450
Medical Specimen Bags Comprehensive Study by Type (Disposable, Reusable), Application (Hospitals, Clinics, Laboratory, Home Care, Other), Distribution Channel (Hospital Pharmacies, Online Pharmacies,...
$ 3350
Breast Surgery Retractors Comprehensive Study by Type (Single-arm Retractors, Double-arm Retractors), Application (Hospitals, Ambulatory Surgical Centers, Gynecology Clinics), Usage Types (Disposable...
$ 3650
Prebiotic Ingredient Comprehensive Study by Type (Inulin, Monosaccharides, Disaccharides, Oligosaccharides, Others), Application (Dairy Products, Dietary Supplements, Animal Feed, Functional Food & B...
$ 3750